Investors & Media

Transformative science, targeted medicines

We are working to advance a deep pipeline of precision therapies, designed to allow patients to live longer, better lives. Our approach combines world-leading expertise in protein kinases with sound execution and an intense focus on discovery.

SEC Filings

SEC Filings

Search
Filing date Form Description View
144

Filed by "insiders" prior intended sale of restricted stock. Non-EDGAR filing

 View HTML
0001968582-23-000700.pdf
0001968582-23-000700.rtf
0001968582-23-000700.xls
144

Filed by "insiders" prior intended sale of restricted stock. Non-EDGAR filing

 View HTML
0001950047-23-005609.pdf
0001950047-23-005609.rtf
144

Filed by "insiders" prior intended sale of restricted stock. Non-EDGAR filing

 View HTML
0001950047-23-005801.pdf
0001950047-23-005801.rtf
0001950047-23-005801.xls
144

Filed by "insiders" prior intended sale of restricted stock. Non-EDGAR filing

 View HTML
0001950047-23-006134.pdf
0001950047-23-006134.rtf
0001950047-23-006134.xls
144

Filed by "insiders" prior intended sale of restricted stock. Non-EDGAR filing

 View HTML
0001950047-23-006422.pdf
0001950047-23-006422.rtf
144

Filed by "insiders" prior intended sale of restricted stock. Non-EDGAR filing

 View HTML
0001968582-24-000049.pdf
0001968582-24-000049.rtf
0001968582-24-000049.xls
144

Filed by "insiders" prior intended sale of restricted stock. Non-EDGAR filing

 View HTML
0001950047-24-001497.pdf
0001950047-24-001497.rtf
0001950047-24-001497.xls
144

Filed by "insiders" prior intended sale of restricted stock. Non-EDGAR filing

 View HTML
0001950047-24-001814.pdf
0001950047-24-001814.rtf
0001950047-24-001814.xls
144

Filed by "insiders" prior intended sale of restricted stock. Non-EDGAR filing

 View HTML
0001972362-24-000411.pdf
0001972362-24-000411.rtf
0001972362-24-000411.xls
144

Filed by "insiders" prior intended sale of restricted stock. Non-EDGAR filing

 View HTML
0001950047-24-002411.pdf
0001950047-24-002411.rtf
0001950047-24-002411.xls